[go: up one dir, main page]

DK24280A - Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse - Google Patents

Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse

Info

Publication number
DK24280A
DK24280A DK24280A DK24280A DK24280A DK 24280 A DK24280 A DK 24280A DK 24280 A DK24280 A DK 24280A DK 24280 A DK24280 A DK 24280A DK 24280 A DK24280 A DK 24280A
Authority
DK
Denmark
Prior art keywords
hydantoines
quinolyl
spiro
procedure
preparation
Prior art date
Application number
DK24280A
Other languages
English (en)
Other versions
DK156399C (da
DK156399B (da
Inventor
R C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK24280A publication Critical patent/DK24280A/da
Publication of DK156399B publication Critical patent/DK156399B/da
Application granted granted Critical
Publication of DK156399C publication Critical patent/DK156399C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK024280A 1979-01-22 1980-01-21 Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater DK156399C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/005,278 US4176185A (en) 1979-01-22 1979-01-22 Spiro-quinolylhydantoins
US527879 1979-01-22

Publications (3)

Publication Number Publication Date
DK24280A true DK24280A (da) 1980-07-23
DK156399B DK156399B (da) 1989-08-14
DK156399C DK156399C (da) 1990-01-08

Family

ID=21715098

Family Applications (1)

Application Number Title Priority Date Filing Date
DK024280A DK156399C (da) 1979-01-22 1980-01-21 Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater

Country Status (22)

Country Link
US (1) US4176185A (da)
EP (1) EP0014079B1 (da)
JP (1) JPS5840959B2 (da)
KR (1) KR830001940A (da)
AR (1) AR222685A1 (da)
AT (1) AT365588B (da)
AU (1) AU514271B2 (da)
CA (1) CA1140928A (da)
DE (1) DE3060079D1 (da)
DK (1) DK156399C (da)
EG (1) EG15085A (da)
ES (1) ES8103090A1 (da)
FI (1) FI69308C (da)
GR (1) GR72408B (da)
IE (1) IE49365B1 (da)
IL (1) IL59177A (da)
NO (1) NO152172C (da)
NZ (1) NZ192650A (da)
PH (1) PH15472A (da)
PT (1) PT70716A (da)
YU (1) YU41692B (da)
ZA (1) ZA80344B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
IE50332B1 (en) * 1979-11-13 1986-04-02 Ici Ltd 1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3261684D1 (en) * 1981-05-12 1985-02-07 Ici Plc Pyrrole derivatives
MX12896A (es) * 1987-09-04 1993-06-01 Pfizer Procedimiento para preparar un compuesto de espiro-heteroazolonas
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3876659A (en) * 1970-09-18 1975-04-08 Sandoz Ag Spiro tricyclic isoindolines
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins

Also Published As

Publication number Publication date
AR222685A1 (es) 1981-06-15
FI800163A (fi) 1980-07-23
NO152172B (no) 1985-05-06
FI69308C (fi) 1986-01-10
ES487923A0 (es) 1981-02-16
IL59177A (en) 1982-11-30
YU13180A (en) 1983-01-21
IL59177A0 (en) 1980-05-30
EP0014079A1 (en) 1980-08-06
NZ192650A (en) 1984-04-27
NO152172C (no) 1985-08-14
DE3060079D1 (en) 1982-01-21
DK156399C (da) 1990-01-08
ES8103090A1 (es) 1981-02-16
CA1140928A (en) 1983-02-08
ZA80344B (en) 1981-02-25
YU41692B (en) 1987-12-31
PH15472A (en) 1983-01-24
IE800109L (en) 1980-07-22
JPS55108873A (en) 1980-08-21
PT70716A (en) 1980-02-01
AT365588B (de) 1982-01-25
ATA26780A (de) 1981-06-15
EP0014079B1 (en) 1981-11-18
AU514271B2 (en) 1981-01-29
GR72408B (da) 1983-11-02
AU5476680A (en) 1980-07-31
EG15085A (en) 1986-12-30
FI69308B (fi) 1985-09-30
NO794318L (no) 1980-07-23
IE49365B1 (en) 1985-09-18
KR830001940A (ko) 1983-05-19
US4176185A (en) 1979-11-27
DK156399B (da) 1989-08-14
JPS5840959B2 (ja) 1983-09-08

Similar Documents

Publication Publication Date Title
NO803330L (no) Elektrolysoer og fremgangsmaate for elektrolysering
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
DK319480A (da) Muramylpeptidforbindelser samt deres fremstilling og anvendelse
NO801469L (no) Pyrimidinforbindelser og fremgangsmaate til deres fremstilling
NO800501L (no) Antibakterielle midler og beta-laktamasehemmere og fremgangsmaate for deres fremstilling
NO150634C (no) Sementholdige blandinger og fremgangsmaate for deres fremstilling
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
DK488180A (da) Tetrazolyloxycarboxylsyreamider fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
NO790934L (no) 2,6-dialkoksybenzamider og fremgangsmaate til deres fremstilling
DK409277A (da) Pentapeptider og fremgangsmaade til deres fremstilling
NO780800L (no) Azoforbindelser og fremgangsmaate til deres fremstilling
DK251281A (da) N6-adenosiner og fremgangsmaader til deres fremstilling
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
DK50677A (da) Thiadiazolylylbenzamider og fremgangsmade til deres fremstilling
DK286480A (da) Oxinethere deres fremstilling og anvendelse
DK111678A (da) Enzym-marumer og fremgangsmaade til deres fremstilling
DK24280A (da) Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse
DK308878A (da) Aminoglyosidderivater og fremgangsmaader til deres fremstilling
NO790047L (no) Kompoundmaterialer og fremgangsmaate til deres fremstilling
DK326980A (da) 25-halogen-cholest-5-en-3beta,22-dioler og estere deraf deres fremstilling og anvendelse
DK63080A (da) 25-hydroxy-24-oxochlostanderivater og fremgangsmaade til fremstilling deraf
DK319478A (da) Angiotensinpeptider og deres fremstilling
DK323378A (da) Imidazo-isoquinolin-dioner og fremgangsmaade til deres fremstilling
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK416278A (da) 2-oxazolidon-derivater og fremgangsmaade til deres fremstilling

Legal Events

Date Code Title Description
PBP Patent lapsed